Palbociclib - Onyx Pharmaceuticals/Pfizer
At a glance
- Drug Originator Onyx Pharmaceuticals; Pfizer; SOLTI Breast Cancer Research Group
- Drug Class 2 ring heterocyclic compounds; Antineoplastics; Cyclopentanes; Ketones; Piperazines; Pyridines; Pyrimidines; Small molecules
- Mechanism of Action Cyclin-dependent kinase 4 inhibitors; Cyclin-dependent kinase 6 inhibitors
- USA Patent Applicants PFIZER
- USA Patents 9
- NDAs 2
- International Patents 166
- Patent Applications 4,077
Table of Contents
Disclaimer